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Monday, February 4, 2013 273abinding to the amino- terminal domain of GluN2 subunits. Interestingly, zinc
inhibits GluN2A- containing receptors at lower concentrations than GluN2B-
containing channels. Luminescence resonance energy transfer (LRET) was
used to study GluN1 and GluN2A subunits of the NMDA receptor. Donor
and acceptor tags were attached through maleimide linkages to non- disulphide
bonded cysteines introduced at key sites to allow the probing of distances and
conformational changes. The amino- terminal domain tetramer organization
was also studied using this LRET technique. The LRET based distances be-
tween sites on the amino- terminal domain of GluN1 and GluN2A in the full
length receptor are similar to the distances in the tetrameric structure of the iso-
lated amino-terminal domains of GluN1- GluN2B and are dissimilar to the
structure of full length AMPA receptor. These results indicate that the full
length receptor has a similar organization as the structure of the isolated amino-
terminal domain of GluN1-GluN2B with the dimers being closely packed.
Additionally, the distances between subunits at the N-terminus of the amino-
terminal domain of GluN2A did not change upon addition of the allosteric
inhibitor zinc or upon binding of the agonists glutamate and glycine to the li-
gand- binding domain. The lack of changes at the amino terminus suggests
that the allosteric modulator- induced conformational changes are propagated
towards the agonist binding domain and in turn to the channel segments.
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N-Methyl-D-Aspartate receptors (NMDARs) are ligand-gated ion channels
that mediate excitatory neurotransmission in the mammalian central nervous
system. They are required for normal neuronal function and are a factor in sev-
eral neuropathies including Alzheimer’s disease and schizophrenia. Classical
NMDARs require both glycine (NR1) and glutamate (NR2) bound for receptor
activation. Reaction mechanisms for NMDA receptors have been developed
for several isoforms, however these models assume saturation of glycine sites
and a quantitative understanding of glycine association and dissociation kinet-
ics is currently inadequate. We measured current responses with fast applica-
tion of glycine (in 1 mM glutamate) onto outside-out patches containing
several NR1/NR2A receptors and observed relatively slow kinetics, with
a rise time of 4.9 5 0.6ms and deactivation of 105 5 8ms. Anticipating
a slow dissociation rate for glycine, we first developed models for two low-
affinity glycine-site full-agonists: L-serine (95% efficacy; EC50=0.21mM)
and 3,3,3-trifluoro-DL-alanine (132% efficacy; EC50=2.2mM). We used these
data to select best fitting multi-state kinetic models of several arrangements
and further validated these with cycles of simulations and experimental mea-
surements which included macroscopic responses to several stimulation pat-
terns. These models will be used to estimate glycine association and
dissociation rate constants. Work is in progress to validate these results with
macroscopic measurements. Knowledge about how glycine gates NMDA
receptors will offer insight to glycine-dependent NR1/NR2A kinetic mecha-
nisms and contribute to a more comprehensive understanding of the activation
of these physiologically important receptors.
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N-methyl-D-aspartate (NMDA) receptors mediate excitatory synaptic trans-
mission in central nervous system and play important roles in development
and synaptic plasticity, but have also been found to mediate neurotoxicity. Re-
cently, 2-naphthoic acid (NPA) and its derivatives have been identified as
allosteric, noncompetitive NMDA receptors inhibitors. The inhibitory selectiv-
ity of NPA derivatives among NMDA receptor subtypes was mapped to the
ligand-binding domain (LBD), and the binding site of NPA is proposed to
be located in the LBD dimer interface. However, the mechanism by which
NPA exerts inhibitory effect is still unclear. We examined how NPA affects
the gating reaction of NMDA receptors. Whole-cell patch clamp on HEK
293 cells expressing recombinant NR1-1a/NR2A showed that NPA has 90%
maximum inhibition with IC50 of 2.1 mM. Furthermore, by recording
single-channel currents from NR1-1a/NR2A receptors with 4 mM NPA, we
found a 62% decrease in open probability (Po), due to a 2.5-fold decrease
in mean open time (MOT) and a 2-fold increase in mean closed time
(MCT). Kinetic modeling suggests NPA increases energy barrier of gating
and destabilizes the open state, thus making NRs accumulate in the closed
states along the activation pathway. These results provide insight into the in-
hibitory mechanism of NPA, and help anticipate its effects on both physiolog-
ical and pathological conditions.1404-Pos Board B296
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Glutamate receptors ion channels (iGluRs) mediate excitatory transmission at
synapses in the vertebrate CNS, but have homologs in bacteria and plants.
We present a structural and functional characterization of AvGluR1, a recently
discovered iGluR from the primitive eukaryote Adineta vaga that has been sug-
gested as an evolutionary intermediate between bacterial and animal iGluRs.
Structure based alignments reveal that AvGluR1 clusters with bacterial recep-
tors, lacks a domain 1 loop and a conserved alpha-helix found in animal iGluR
ligand binding domains (LBDs), but contains a disulfide bond found only in eu-
karyotic iGluRs. Although AvGluR1 crystallizes as a dimer that superposes
well on the LBD of the intact rat GluA2 receptor structure, the isolated LBD
does not measurably interact even at protein concentrations as high as
135mM. Competitive [3H]-glutamate displacement assays for AvGluR1 LBD
as well as electrophysiological experiments on the intact receptor, demonstrate
that in addition to Glu, Asp and Ser, the hydrophobic amino acids Ala, Met and
Phe can also bind to and activate AvGluR1, producing moderately rapid and
fully desensitizing responses. Crystal structures of AvGluR1 LBD complexes
with Glu, Asp, Ser and Ala reveal a novel binding mechanism involving two
domain 2 Arg residues that directly coordinate the gamma-carboxyl group of
Glu/Asp. Binding of neutral amino acids like Ser/Ala also utilizes a unique
mechanism in which a Cl- ion substitutes for gamma carboxyl group of Glu,
acting as a countercharge for domain 2 Arg residues. [3H]-glutamate binding
experiments establish that the absence of Cl- drastically lowers the receptor’s
affinity for Ser/Ala but not Glu/Asp. Thus the present work illustrates a novel
scheme for the binding of multiple dissimilar ligands that may be utilized by the
distantly related odorant/chemosensory receptors, while emphasizing the need
for additional structure-based studies on iGluR-ligand interactions.
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2,3-Benzodiazepine (2,3-BDZ) compounds are a group of AMPA receptor in-
hibitors and are drug candidates for treating neurological diseases involving ex-
cessive AMPA receptor activity. We investigated the mechanism by which
GluA2Qflip receptor channel opening is inhibited by two 2,3-BDZ derivatives,
i.e. (2,3-BDZ-11-2) and its 1-(4-amino-3-chlorophenyl) analogue (2,3-BDZ-
11-4). Both compounds have a 7,8-ethylenedioxy moiety instead of the
7,8-methylenedioxy feature in the structure of GYKI 52466, the prototypic
2,3-BDZ compound. Using a laser-pulse photolysis approach with a time reso-
lution of ~60 ms and a rapid solution flow technique, we characterized the effect
of the two compounds on the channel-opening process of the homomeric
GluA2Qflip receptor. Both 2,3-BDZ-11-2 and 2,3-BDZ-11-4 inhibit the receptor
noncompetitively with specificity for the closed-channel conformation of the
GluA2Qflip receptor. 2,3-BDZ-11-4 is ~10-fold stronger, defined by its inhibi-
tion constant for the closed-channel conformation (i.e., KI = 2 mM), than
2,3-BDZ-11-2. From double-inhibitor experiments, we find that both com-
pounds bind to the same site, but this site is different from the two other non-
competitive sites we reported earlier (Ritz et al., 2008, Ritz et al., 2011). In
other words, 2,3-BDZ-11-2 and 2,3-BDZ-11-4 do not bind to either the site
where GYKI 52466 binds or the site where 2,3-BDZ-2 binds (see their struc-
tures below). Our results provide mechanistic clues to better understand
AMPA receptor regulation and establish a structure-activity relationship for de-
signing more potent 2,3-BDZ compounds with predictable properties for this
new noncompetitive site.
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NMDA receptors (NMDARs) are heterotetrameric glutamate-gated ion chan-
nels, typically composed of 2 GluN1 and 2 GluN2 subunits. The central func-
tion of NMDARs is gating - the process of converting agonist binding energy
into pore opening by repositioning M3, the major pore-lining transmembrane
helix. For glutamate receptors, it is largely assumed, though lacking direct
evidence, that gating occurs through tension: ligand-binding domain (LBD)
closure around an agonist generates tension in the linkers connecting the
LBD to M3 (the M3-S2 linker), shifting M3 away from the central pore axis.
